Liquidia Newsroom

Liquidia Analyst Ratings

BenzingaJun 25 13:54 ET

Liquidia Analyst Ratings

BenzingaJun 3 07:18 ET

Maintaining Buy Rating on Liquidia Technologies Amidst FDA Delay, Optimistic on Yutrepia's Market Potential

TipRanksMay 15 10:30 ET

Liquidia Analyst Ratings

BenzingaMay 15 05:50 ET

Bullish Outlook for Liquidia Technologies With Buy Rating Amid Anticipated Patent Clarity and Market Growth Opportunities

TipRanksMay 14 15:40 ET

Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Liquidia Technologies (LQDA) and Pacific Biosciences (PACB)

TipRanksMay 14 13:15 ET

Buy Rating for Liquidia Technologies: Innovation and Market Potential Drive Strong Investment Case

TipRanksApr 10 07:05 ET

Liquidia Analyst Ratings

BenzingaApr 10 07:02 ET

Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT), Liquidia Technologies (LQDA) and Xtant Medical Holdings (XTNT)

TipRanksApr 2 05:15 ET

Buy Rating Justified by Favorable Legal Outcomes and Imminent FDA Decision for Liquidia Technologies' Yutrepia

TipRanksApr 1 10:40 ET

Liquidia Analyst Ratings

BenzingaApr 1 10:28 ET

Liquidia Analyst Ratings

BenzingaMar 14 12:01 ET

Liquidia Technologies Faces Sell Rating Amid Legal Struggles and Market Competition

TipRanksMar 14 10:30 ET

Buy Rating Affirmed for Liquidia Technologies With Doubling Price Target on Yutrepia's Promising Prospects

TipRanksMar 14 06:32 ET

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA) and Legend Biotech (LEGN)

TipRanksMar 14 06:15 ET

Liquidia Analyst Ratings

BenzingaMar 13 16:10 ET

Buy Rating Affirmed for Liquidia Technologies Amid Favorable Legal Rulings and Yutrepia's Market Potential

TipRanksMar 13 15:00 ET

Liquidia Analyst Ratings

BenzingaFeb 21 13:16 ET

Buy Rating Affirmed for Liquidia Technologies Amidst Strong Market Growth and Favorable Regulatory Outlook

TipRanksFeb 21 13:15 ET

Maintaining Buy Rating on Liquidia Technologies Amid FDA Delay: A Procedural Hiccup, Not a Setback

TipRanksJan 25 11:05 ET